Facebook Twitter LinkedIn Google Plus RSS

Antares Pharma enters marketing agreement worth up to $20M for psoriasis treatment

By ,

Ewing-based Antares Pharma Inc. announced today its exclusive promotion and marketing agreement with Denmark-based LEO Pharma regarding the latter company's Otrexup psoriasis treatment.

According to the announcement, Antares will receive a $5 million initial payment and up to $15 million in additional milestone payments. Antares Pharma will record all product revenue associated with future dermatology prescriptions and pay LEO Pharma a percentage of Otrexup net sales generated in dermatology. LEO Pharma will be responsible for promotion and marketing activities in dermatology.

Antares appointed a new senior vice president for medical earlier this month.

More From This Industry

Write to the Editorial Department at editorial@njbiz.com

Related Stories

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy


Subscribe to Our Newsletters!
Click Here to Subscribe for Free Now!